HealthEquity, Inc. (NASDAQ:HQY) Director Sells $639,917.50 in Stock

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

HealthEquity Price Performance

Shares of HQY stock traded down $1.25 during trading hours on Friday, hitting $112.69. The company had a trading volume of 483,217 shares, compared to its average volume of 763,365. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The firm has a market capitalization of $9.77 billion, a price-to-earnings ratio of 103.39, a PEG ratio of 1.61 and a beta of 0.55. The firm's fifty day moving average is $102.14 and its 200 day moving average is $90.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the business earned $0.40 earnings per share. On average, sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Institutional Investors Weigh In On HealthEquity

A number of large investors have recently bought and sold shares of HQY. Truist Financial Corp grew its position in HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company's stock worth $247,000 after acquiring an additional 188 shares during the last quarter. GAMMA Investing LLC lifted its holdings in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after buying an additional 344 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in HealthEquity by 17.3% during the 3rd quarter. Exchange Traded Concepts LLC now owns 9,568 shares of the company's stock worth $783,000 after buying an additional 1,414 shares in the last quarter. Paladin Wealth LLC acquired a new position in HealthEquity during the 3rd quarter worth $39,000. Finally, Creative Planning lifted its holdings in HealthEquity by 18.6% during the 3rd quarter. Creative Planning now owns 23,632 shares of the company's stock worth $1,934,000 after buying an additional 3,706 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on HQY. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. BTIG Research boosted their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Barrington Research boosted their price target on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Monday, December 2nd. Finally, Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target on the stock. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, HealthEquity presently has an average rating of "Moderate Buy" and a consensus target price of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.